Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ismini Chatzitheofilou"'
Autor:
Dominic Muston, Jean-Francois Korobelnik, Tim Reason, Neil Hawkins, Ismini Chatzitheofilou, Fay Ryan, Peter K. Kaiser
Publikováno v:
BMC Ophthalmology, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background This was an updated network meta-analysis (NMA) of anti-vascular endothelial growth factor (VEGF) agents and laser photocoagulation in patients with diabetic macular edema (DME). Unlike previous NMA that used meta-regression to ac
Externí odkaz:
https://doaj.org/article/392c422db02c4475a4e1906ccf9b8121
Autor:
João Morais, Carlos Aguiar, Euan McLeod, Ismini Chatzitheofilou, Isabel Fonseca Santos, Sónia Pereira
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 33, Iss 9, Pp 535-544 (2014)
Introduction and Aims: To project the long-term cost-effectiveness of treating non-valvular atrial fibrillation (AF) patients for stroke prevention with rivaroxaban compared to warfarin in Portugal. Methods: A Markov model was used that included heal
Externí odkaz:
https://doaj.org/article/29bf739f07b94d28acede0af8dc6e0da
Autor:
Isabel Fonseca Santos, Sónia Pereira, Euan McLeod, Anne-Laure Guillermin, Ismini Chatzitheofilou
Publikováno v:
Acta Médica Portuguesa, Vol 27, Iss 5 (2014)
Introduction: Venous thromboembolism is a burden on healthcare systems. The aim of this analysis was to project the long-term costs and outcomes for rivaroxaban compared to standard of care (enoxaparin/warfarin) in Portugal for the treatment and seco
Externí odkaz:
https://doaj.org/article/6cfbfb149adb4289b2fce02abb7119c6
Autor:
Tim Reason, Jean-François Korobelnik, Neil Hawkins, Fay Ryan, Dominic Muston, Peter K. Kaiser, Ismini Chatzitheofilou
Publikováno v:
BMC Ophthalmology, Vol 18, Iss 1, Pp 1-11 (2018)
BMC Ophthalmology
BMC Ophthalmology, BioMed Central, 2018, 18 (1), pp.340. ⟨10.1186/s12886-018-1006-9⟩
BMC Ophthalmology
BMC Ophthalmology, BioMed Central, 2018, 18 (1), pp.340. ⟨10.1186/s12886-018-1006-9⟩
Background This was an updated network meta-analysis (NMA) of anti-vascular endothelial growth factor (VEGF) agents and laser photocoagulation in patients with diabetic macular edema (DME). Unlike previous NMA that used meta-regression to account for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::024c2901615ab889900fb2ce686c9690
https://doi.org/10.1186/s12886-018-1006-9
https://doi.org/10.1186/s12886-018-1006-9
Autor:
Muston, Dominic, Jean-Francois Korobelnik, Reason, Tim, Hawkins, Neil, Ismini Chatzitheofilou, Ryan, Fay, Kaiser, Peter
Appendix 1. Statistical methods and covariable adjustments. (DOCX 57 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4feea0e9710bcd47d43c4ce5bad8972e
Autor:
Muston, Dominic, Jean-Francois Korobelnik, Reason, Tim, Hawkins, Neil, Ismini Chatzitheofilou, Ryan, Fay, Kaiser, Peter
Appendix 2. Treatment regimens classified and included in the NMA. (DOCX 64 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1211413fd3aca6f51c7169d365004f1d
Autor:
Muston, Dominic, Jean-Francois Korobelnik, Reason, Tim, Hawkins, Neil, Ismini Chatzitheofilou, Ryan, Fay, Kaiser, Peter
Appendix 3. Overview of outcomes of studies included in the NMA. (DOCX 68 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5aab8d953942c364c0cafdd3aebe28a
Autor:
Tatiana, Dilla, Dimitra, Alexiou, Ismini, Chatzitheofilou, Ruba, Ayyub, Julia, Lowin, Kirsi, Norrbacka
Publikováno v:
Journal of medical economics. 20(5)
Dulaglutide 1.5 mg once weekly is a novel glucagon-like peptide 1 (GLP-1) receptor agonist, for the treatment of type two diabetes mellitus (T2DM). The objective was to estimate the cost-effectiveness of dulaglutide once weekly vs liraglutide 1.8 mg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a43654c5f8294ef8bd6a60a190ce1101
https://pubmed.ncbi.nlm.nih.gov/28008768
https://pubmed.ncbi.nlm.nih.gov/28008768
Publikováno v:
Acta Médica Portuguesa; v. 27, n. 5 (2014): Setembro-Outubro; 615-624
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Venous thromboembolism is a burden on healthcare systems. The aim of this analysis was to project the long-term costs and outcomes for rivaroxaban compared to standard of care (enoxaparin/warfarin) in Portugal for the treatment and secondary preventi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35d6ea551b051958491fb5532d1b7db2
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5257
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5257